Binnacle Investments Inc Argenx Se Put Options Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ARGX
# of Institutions
475Shares Held
28.7MCall Options Held
308KPut Options Held
239K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$3.02 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.56 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.3 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.94MShares$1.09 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$695 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $31B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...